COVID19 is a respiratory infection caused by the novel SARS-CoV-2 virus that was first identified in late 2019. Due to the precipitous progression of disease, high mortality rate, and swift spread across communities, this global pandemic is now a public health emergency. The Centers for Disease Control and Prevention list asthma as a risk factor for severe COVID19 infection. However, to date there is very limited data regarding the frequency and severity of COVID19 among adults and children with asthma. In this current study we will determine the prevalence of underlying asthma diagnosis among hospitalized patients with COVID19 and characterize the clinical course of disease among patients with history of asthma.